Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)
Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence...
Gespeichert in:
Veröffentlicht in: | Behavioural brain research 2024-01, Vol.456, p.114708-114708, Article 114708 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 114708 |
---|---|
container_issue | |
container_start_page | 114708 |
container_title | Behavioural brain research |
container_volume | 456 |
creator | Nawata, Yoko Ooishi, Rina Nishioku, Tsuyoshi Yamaguchi, Taku |
description | Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence.
•We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence. |
doi_str_mv | 10.1016/j.bbr.2023.114708 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2876636274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0166432823004266</els_id><sourcerecordid>2876636274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</originalsourceid><addsrcrecordid>eNp9kM1OGzEUhS1UJFLgAdh5SReT-C_zI1YoaiFS1EoI1pbtuZNxmLEH2xOJZ-hL4yhdd3Xu4nzn6hyE7ihZUkLL1WGpdVgywviSUlGR-gItaF2xolqL5htaZE9ZCM7qK_Q9xgMhRJA1XaC_v9UwQgcOsEoJ3KwSRBzAupjyOYJL2Hd4hNSrceohqdE6KCLAu3V7rKFXR-sDtg4HlSJOffDzvsf7LBPebk-k0j4FP1mD98OcA3Ju_mBgSj5EfD8-DfMLW_EfN-iyU0OE2396jd5-_XzdPBe7P0_bzeOuMKxmqWipMMasNRhKgdVaq6atu7IiouWt4rRpuoaKtmKiplQb6Jq1Ilw3wBWotiv5Nbo_507Bf8wQkxxtNDAMyoGfo2R1VZa8ZJXIVnq2muBjDNDJKdhRhU9JiTwNLw8yDy9Pw8vz8Jl5ODOQOxwtBBmNBWegtbl1kq23_6G_AGLGjyk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2876636274</pqid></control><display><type>article</type><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><source>Access via ScienceDirect (Elsevier)</source><creator>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</creator><creatorcontrib>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</creatorcontrib><description>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence.
•We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/j.bbr.2023.114708</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Drug-seeking behavior ; Methamphetamine ; mGluR2/3 ; Nalmefene ; Self-administration</subject><ispartof>Behavioural brain research, 2024-01, Vol.456, p.114708-114708, Article 114708</ispartof><rights>2023 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.bbr.2023.114708$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Nawata, Yoko</creatorcontrib><creatorcontrib>Ooishi, Rina</creatorcontrib><creatorcontrib>Nishioku, Tsuyoshi</creatorcontrib><creatorcontrib>Yamaguchi, Taku</creatorcontrib><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><title>Behavioural brain research</title><description>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence.
•We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</description><subject>Drug-seeking behavior</subject><subject>Methamphetamine</subject><subject>mGluR2/3</subject><subject>Nalmefene</subject><subject>Self-administration</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kM1OGzEUhS1UJFLgAdh5SReT-C_zI1YoaiFS1EoI1pbtuZNxmLEH2xOJZ-hL4yhdd3Xu4nzn6hyE7ihZUkLL1WGpdVgywviSUlGR-gItaF2xolqL5htaZE9ZCM7qK_Q9xgMhRJA1XaC_v9UwQgcOsEoJ3KwSRBzAupjyOYJL2Hd4hNSrceohqdE6KCLAu3V7rKFXR-sDtg4HlSJOffDzvsf7LBPebk-k0j4FP1mD98OcA3Ju_mBgSj5EfD8-DfMLW_EfN-iyU0OE2396jd5-_XzdPBe7P0_bzeOuMKxmqWipMMasNRhKgdVaq6atu7IiouWt4rRpuoaKtmKiplQb6Jq1Ilw3wBWotiv5Nbo_507Bf8wQkxxtNDAMyoGfo2R1VZa8ZJXIVnq2muBjDNDJKdhRhU9JiTwNLw8yDy9Pw8vz8Jl5ODOQOxwtBBmNBWegtbl1kq23_6G_AGLGjyk</recordid><startdate>20240105</startdate><enddate>20240105</enddate><creator>Nawata, Yoko</creator><creator>Ooishi, Rina</creator><creator>Nishioku, Tsuyoshi</creator><creator>Yamaguchi, Taku</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240105</creationdate><title>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</title><author>Nawata, Yoko ; Ooishi, Rina ; Nishioku, Tsuyoshi ; Yamaguchi, Taku</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-d14ccc5bec11e28bba9d8f6704d3da3199f914d724811bcef95a03b9e3aeadf63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Drug-seeking behavior</topic><topic>Methamphetamine</topic><topic>mGluR2/3</topic><topic>Nalmefene</topic><topic>Self-administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nawata, Yoko</creatorcontrib><creatorcontrib>Ooishi, Rina</creatorcontrib><creatorcontrib>Nishioku, Tsuyoshi</creatorcontrib><creatorcontrib>Yamaguchi, Taku</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nawata, Yoko</au><au>Ooishi, Rina</au><au>Nishioku, Tsuyoshi</au><au>Yamaguchi, Taku</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3)</atitle><jtitle>Behavioural brain research</jtitle><date>2024-01-05</date><risdate>2024</risdate><volume>456</volume><spage>114708</spage><epage>114708</epage><pages>114708-114708</pages><artnum>114708</artnum><issn>0166-4328</issn><eissn>1872-7549</eissn><abstract>Nalmefene, an analog to naltrexone, is an antagonist at the μ opioid receptor and a partial agonist at the κ opioid receptor. Both agents are approved for the treatment of alcohol use disorder and opioid addiction. Here, we evaluated the potential of nalmefene for treating psychostimulant dependence using a methamphetamine (METH) self-administration rat model. Rats were trained to press a lever for 0.02-mg intravenous METH infusions paired with drug-associated cues (light and tone) under a fixed ratio 1 schedule. After a 10-day METH self-administration acquisition phase, rats underwent extinction training. A reinstatement test was conducted after fulfilment of the extinction criterion under saline infusions. Re-exposure to METH-associated cues or a priming injection of METH (1.0 mg/kg, i.p.) significantly reinstated METH-seeking behaviors. Pretreatment with nalmefene (10 mg/kg, i.p.) immediately before reinstatement tests significantly attenuated the METH-seeking behaviors induced by both cues and METH priming injection. To investigate the mechanism of effect of nalmefene, we also tested the ability of a group II metabotropic glutamate receptors (mGluR2/3) antagonist, LY341495, to the ameliorating effects of nalmefene. Pretreatment with LY341495 (1.0 mg/kg, i.p.) before nalmefene administration antagonized the effect of nalmefene on reinstatement. LY341495 alone did not affect the reinstatement of lever pressing. We found that nalmefene attenuates METH-seeking behaviors during withdrawal, and this attenuation of reinstatement is mediated by the activation of mGluR2/3. The present findings suggest that nalmefene could decrease incentive motivation for drug use in psychostimulant dependence.
•We examined the potential of nalmefene for treating psychostimulant dependence.•Nalmefene attenuates methamphetamine-seeking behaviors in rats.•mGluR2/3 antagonist reverses the attenuating effect of nalmefene on reinstatement.•Nalmefene may be useful for an anti-craving agent in psychostimulant dependence.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.bbr.2023.114708</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0166-4328 |
ispartof | Behavioural brain research, 2024-01, Vol.456, p.114708-114708, Article 114708 |
issn | 0166-4328 1872-7549 |
language | eng |
recordid | cdi_proquest_miscellaneous_2876636274 |
source | Access via ScienceDirect (Elsevier) |
subjects | Drug-seeking behavior Methamphetamine mGluR2/3 Nalmefene Self-administration |
title | Nalmefene attenuates reinstatement of methamphetamine-seeking behavior in rats through group II metabotropic glutamate receptors (mGluR2/3) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A17%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nalmefene%20attenuates%20reinstatement%20of%20methamphetamine-seeking%20behavior%20in%20rats%20through%20group%20II%20metabotropic%20glutamate%20receptors%20(mGluR2/3)&rft.jtitle=Behavioural%20brain%20research&rft.au=Nawata,%20Yoko&rft.date=2024-01-05&rft.volume=456&rft.spage=114708&rft.epage=114708&rft.pages=114708-114708&rft.artnum=114708&rft.issn=0166-4328&rft.eissn=1872-7549&rft_id=info:doi/10.1016/j.bbr.2023.114708&rft_dat=%3Cproquest_cross%3E2876636274%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2876636274&rft_id=info:pmid/&rft_els_id=S0166432823004266&rfr_iscdi=true |